Precision BioSciences Growth, Revenue, Number of Employees and Funding
Revenue & Financials
- Precision BioSciences's revenue is currently $10.8M per year.
- Precision BioSciences received $40.0M in venture funding in March 2019.
- Precision BioSciences's revenue per employee is $93478
- Precision BioSciences's total funding is $153.3M.
- Precision BioSciences has 115 Employees.
- Precision BioSciences grew their employee count by 19% last year.
- Precision BioSciences currently has 17 job openings.
What Is Precision BioSciences?
Precision BioSciences is a privately held biotechnology company dedicated to improving lives through its next generation gene editing technology, ARCUS. Precision's cell therapy, gene therapy, and agriculture programs are based on the proprietary ARC endonuclease, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow not to mention plentifully stocked kitchens and benefits like wellness massage. At Precision BioSciences, we are excited to work together toward improving lives by realizing the potential of gene editing.keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
|Name||Revenue||Number of Employees||Employee Growth||Total Funding|
Precision BioSciences News
Precision Biosciences has priced their initial public offering between $15-17 per share, meaning their coming IPO has the potential to make the
DURHAM — Precision BioSciences Inc., which earlier this month filed to raise $100 million in an initial public offering, has raised $39.5 million
Precision BioSciences sets IPO terms. Mar. 18, 2019 6:50 AM ET |About: Precision BioSciences (DTIL)|By: Douglas W. House, SA News Editor. Precision
Precision BioSciences Funding
Precision BioSciences Executive Hires
|2015-09-03||Gene Liau||SVP (Gene Therapy)||Article|
|2017-07-11||David Thomson||Chief Development Officer||Article|
Precision BioSciences New Location/Offices